[ACL] QoQ Quarter Result on 30-Sep-2022 [#Q1]

Stock
[ACL] Australian Clinical Labs Limited
Announcement Date
29-Sep-2022
Financial Year
2023
Quarter
30-Sep-2022 [#Q1]
Profit Trend
QoQ- -73.54%
YoY- -80.48%
Quarter Report
ACL's Result
ACL's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 336,760 168,380 360,312 180,156 457,603 228,802 538,001 -26.88%
PBT 15,554 7,777 32,756 16,378 69,956 34,978 184,944 -80.89%
Tax 4,994 2,497 7,274 3,637 21,842 10,921 54,656 -79.80%
NP 10,480 5,240 25,421 12,711 48,030 24,015 130,214 -81.44%
Tax Rate -32.11% -32.11% -22.21% -22.21% -31.22% -31.22% -29.55% -
Total Cost 326,280 163,140 334,891 167,446 409,573 204,787 407,787 -13.84%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin 3.11 3.11 7.06 7.06 10.50 10.50 24.20 -74.62%
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS 0.05 0.03 0.13 0.06 0.24 0.12 0.65 -81.99%
EPS Diluted 0.05 0.03 0.13 0.06 0.24 0.12 0.65 -81.99%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.